FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children
- 5 May 1999
- journal article
- clinical trial
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 32 (6) , 411-415
- https://doi.org/10.1002/(sici)1096-911x(199906)32:6<411::aid-mpo3>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemiaAmerican Journal of Hematology, 1998
- Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trialBritish Journal of Haematology, 1998
- Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experienceBritish Journal of Haematology, 1998
- Treatment of Relapsed Adult Acute Lymphoblastic Leukemia with Fludarabine and Cytosine Arabinoside Followed by Granulocyte Colony-Stimulating Factor (FLAG-GCSF)Leukemia & Lymphoma, 1997
- Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemiaBlood, 1996
- Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL XThe Lancet, 1995
- Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP*experienceBritish Journal of Haematology, 1994
- The Expanding Role of Fludarabine in Hematologic MalignanciesLeukemia & Lymphoma, 1994
- Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous LeukemiaLeukemia & Lymphoma, 1993
- Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM groupBlood, 1991